ICU Medical (NASDAQ:ICUI – Get Free Report) and Guided Therapeutics (OTCMKTS:GTHP – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, institutional ownership, valuation and profitability.
Profitability
This table compares ICU Medical and Guided Therapeutics’ net margins, return on equity and return on assets.
Get ICU Medical alerts:
Valuation and Earnings
This table compares ICU Medical and Guided Therapeutics”s revenue, earnings per share (EPS) and valuation.
Guided Therapeutics has lower revenue, but higher earnings than ICU Medical. ICU Medical is trading at a lower price-to-earnings ratio than Guided Therapeutics, indicating that it is currently the more affordable of the two stocks.
Institutional and Insider Ownership
96.1% of ICU Medical shares are owned by institutional investors. Comparatively, 9.7% of Guided Therapeutics shares are owned by institutional investors. 1.5% of ICU Medical shares are owned by insiders. Comparatively, 66.8% of Guided Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Analyst Ratings
This is a breakdown of recent recommendations for ICU Medical and Guided Therapeutics, as reported by MarketBeat.
ICU Medical currently has a consensus target price of $181.00, indicating a potential upside of 40.20%. Given ICU Medical’s stronger consensus rating and higher possible upside, equities analysts plainly believe ICU Medical is more favorable than Guided Therapeutics.
Volatility and Risk
ICU Medical has a beta of 0.86, indicating that its share price is 14% less volatile than the S&P 500. Comparatively, Guided Therapeutics has a beta of 0.32, indicating that its share price is 68% less volatile than the S&P 500.
Summary
ICU Medical beats Guided Therapeutics on 9 of the 15 factors compared between the two stocks.
About ICU Medical
(Get Free Report)
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer’s, ringer’s, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer’s irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company’s customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.
About Guided Therapeutics
(Get Free Report)
Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.
Critical Survey: Guided Therapeutics (OTCMKTS:GTHP) versus ICU Medical (NASDAQ:ICUI)
